Compare ALKT & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKT | LMAT |
|---|---|---|
| Founded | 2007 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.9B |
| IPO Year | 2021 | 2006 |
| Metric | ALKT | LMAT |
|---|---|---|
| Price | $14.43 | $83.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 8 |
| Target Price | $19.86 | ★ $107.00 |
| AVG Volume (30 Days) | ★ 2.0M | 215.1K |
| Earning Date | 10-28-2026 | 11-04-2026 |
| Dividend Yield | N/A | ★ 1.20% |
| EPS Growth | N/A | ★ 30.57 |
| EPS | N/A | ★ 1.42 |
| Revenue | $152,159,000.00 | ★ $249,602,000.00 |
| Revenue This Year | $19.44 | $10.79 |
| Revenue Next Year | $16.64 | $9.54 |
| P/E Ratio | ★ N/A | $58.67 |
| Revenue Growth | ★ 35.68 | 13.53 |
| 52 Week Low | $13.21 | $78.22 |
| 52 Week High | $24.47 | $118.01 |
| Indicator | ALKT | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 33.03 | 52.00 |
| Support Level | $13.21 | $78.35 |
| Resistance Level | $14.52 | $83.15 |
| Average True Range (ATR) | 0.48 | 2.32 |
| MACD | 0.13 | 0.31 |
| Stochastic Oscillator | 35.16 | 59.37 |
Alkami Technology Inc is a cloud-based digital banking solutions provider. The company offers the Alkami Digital Sales & Service Platform, which includes a digital banking platform, onboarding and account opening solutions, and data and marketing tools. The platform enables financial institutions to onboard and engage users, support revenue growth, and improve operational efficiency through a cloud-based, multi-tenant architecture. The company provides services to clients under software-as-a-service arrangements. It derives substantially all of its revenues from SaaS subscription services charged for the use of digital sales and service solutions.
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.